Bioptimus announces a $76M funding milestone, with the latest injection of $41M led by Cathay Innovation less than 12 months from its initial seed round Since the successful release of the largest AI foundation model for pathology in July, the company has been continuing its groundbreaking work and is now poised to release a breakthrough […]
Paris, France – November 18th, 2024 – BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence software, designed to transform prenatal ultrasound evaluations of the fetal heart. This milestone marks a significant breakthrough in one of the most challenging and critical […]
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza’s commitment to helping customers deliver innovative new therapies to patients by offering a comprehensive service offering for differentiated ADCs BigHat’s artificial intelligence (AI)/machine learning (ML)-powered antibody design platform, Milliner™ was used to design a highly differentiated […]
Copenhagen and Singapore, 25 June 2024 – Novo Holdings today announced that it has led an investment in AgNext Technologies Private Limited, a breakthrough agricultural and food technology company enhancing trust along the food chains by innovating artificial intelligence-based food quality assessment technologies. Founded in 2016 with operations in India and Abu Dhabi, UAE, AgNext Technologies […]
Methinks Stroke Suite is a disruptive technology that has the potential to provide early, automated detection of large vessel occlusions, both hyperdense and not, from non-contrast computed tomographies BARCELONA, February 21, 2023 – Methinks, a digital health Company that specializes in early detection and management of Acute Stroke (AS), using artificial intelligence (AI), today announced […]
